Company / R&D per Share
Medtronic R&D per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.13
FY2026
5-year range
$1.73 / $2.13
FY2022-FY2026
Trend
+3.8%
vs FY2025
Sector context
#43 of 108
Health Care
What the data says
At $2.13, Medtronic's r&d per share ranks #43 of 108 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $1.73 in FY2022 to $2.13 in FY2026.
Based on SEC 10-K filings.
2.13 in FY2026 with a 5-year CAGR of +4.2%.
Improved from $2.05 to $2.13 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#43 of 108 in Health CareTop 40% of 108This company $2.13 Sector average $2.07
▼
+3.0% above sector average
Key checks
Key Insights
- Medtronic's r&d per share has grown for 4 consecutive years.
- In FY2026, r&d per share increased 3.8% year-over-year.
- Ranks #43 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2017.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.13 | +3.8% |
| FY2025 | $2.06 | +0.1% |
| FY2024 | $2.05 | +9.6% |
| FY2023 | $1.87 | +8.1% |
| FY2022 | $1.73 | -0.3% |
| FY2021 | $1.74 | -6.6% |
| FY2020 | $1.86 | +8.0% |
| FY2019 | $1.72 | +1.2% |
| FY2018 | $1.70 | +5.5% |
| FY2017 | $1.61 | +4.5% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026